Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania.
about
The clinical efficacy of artemether/lumefantrine (Coartem)Misclassification of drug failure in Plasmodium falciparum clinical trials in southeast AsiaPlasmodium falciparum drug resistance in AngolaSpatial Distribution of Falciparum Malaria Infections in Zanzibar: Implications for Focal Drug Administration Strategies Targeting Asymptomatic Parasite Carriers.Genetic diversity among Plasmodium falciparum field isolates in Pakistan measured with PCR genotyping of the merozoite surface protein 1 and 2.Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.Detectability of Plasmodium falciparum clones.Genetic diversity in merozoite surface protein-1 and 2 among Plasmodium falciparum isolates from malarious districts of tribal dominant state of Jharkhand, India.How much remains undetected? Probability of molecular detection of human Plasmodia in the fieldRevisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective studyPlasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malaria.Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphismsExtensive dynamics of Plasmodium falciparum densities, stages and genotyping profiles.Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, TanzaniaPolymorphism in PfMRP1 (Plasmodium falciparum multidrug resistance protein 1) amino acid 1466 associated with resistance to sulfadoxine-pyrimethamine treatment.In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in AfricaEvaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia.Usefulness of Plasmodium falciparum-specific rapid diagnostic tests for assessment of parasite clearance and detection of recurrent infections after artemisinin-based combination therapy.Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria.Malaria Control Interventions Contributed to Declines in Malaria Parasitemia, Severe Anemia, and All-Cause Mortality in Children Less Than 5 Years of Age in Malawi, 2000-2010.Identifying Recrudescent Plasmodium falciparum in Treated Malaria Patients by Real-time PCR and High Resolution Melt Analysis of Genetic Diversity.
P2860
Q21034141-95700025-1B49-469D-BECE-22F9FCEC727EQ24653304-9CD99EDB-3CEA-4DBF-94A9-7D3D86805201Q28075079-E9BB506D-A5C3-4DEF-AB7A-1CA165E1640BQ33589268-D4F94ABC-6DD3-4F1A-99B2-8C7C5920C66BQ33590165-33AA4183-F71B-4B4F-9163-8412C6C20ABDQ33635019-58604430-A84F-49C5-BB2D-60B8688D945CQ33662597-01E4A3B9-903A-4937-AA9E-A04D92F41957Q33873650-C111CD46-BB2D-4B1E-B50F-D5C8D6733A93Q33892663-15447698-7FC6-4E96-97EB-EF5977AF524FQ33898575-75C6CF26-C5FE-4B43-869E-C393AC5151D1Q34290067-6AE0744C-4951-4E2A-9762-D984B93D962AQ34728230-3D398305-B57A-488F-AB72-B7A3B8492472Q35761064-74E611AA-BA3E-4487-8DCC-E772D48DF801Q36584636-6DEABB9A-D146-4DBA-813C-FA8733074B1AQ37020328-8D6783DC-D22E-4C96-B022-4A8CF958E076Q37066203-3E5C4421-0712-4E42-A8D9-5B94ED949FF2Q37204143-7291121D-3D99-45C0-9259-EE80F7DE552DQ37283105-013282FD-ABF4-44FF-B8F7-7033D36AFE17Q37315145-8182F7EB-21B0-465F-AE05-DEDE3E2AF2EDQ37362024-C39EC25C-5E77-4FEE-9D16-75DA38E0CE8CQ37857327-8360E649-40AA-4A31-A18B-CCA7E65051D6Q44168810-70558DB7-9649-482F-A398-1C0D1A7F2475Q55669580-C1E6A1B1-16DE-4DE7-A706-7BD1B5B5D931
P2860
Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Influence of consecutive-day b ...... g trial conducted in Tanzania.
@en
Influence of consecutive-day b ...... g trial conducted in Tanzania.
@nl
type
label
Influence of consecutive-day b ...... g trial conducted in Tanzania.
@en
Influence of consecutive-day b ...... g trial conducted in Tanzania.
@nl
prefLabel
Influence of consecutive-day b ...... g trial conducted in Tanzania.
@en
Influence of consecutive-day b ...... g trial conducted in Tanzania.
@nl
P2093
P50
P356
P1476
Influence of consecutive-day b ...... g trial conducted in Tanzania.
@en
P2093
Andreas Martensson
Billy Ngasala
Christopher Membi
Lisa Wiklund
M Isabel Veiga
Zul Premji
P304
P356
10.1086/510910
P407
P577
2007-01-05T00:00:00Z